Sinovac Announces Positive Preliminary Results of Phase I/II Clinical Trials for Inactivated Vaccine Candidate Against COVID-19 Gallery Sinovac Announces Positive Preliminary Results of Phase I/II Clinical Trials for Inactivated Vaccine Candidate Against COVID-19 中国投资项目 Sinovac Announces Positive Preliminary Results of Phase I/II Clinical Trials for Inactivated Vaccine Candidate Against COVID-19 2022-03-09 14:27:57 03月 09日, 2022 | 阅读更多
Genetron Health Announces Pricing of Initial Public Offering Gallery Genetron Health Announces Pricing of Initial Public Offering 中国投资项目 Genetron Health Announces Pricing of Initial Public Offering 2022-03-09 14:26:54 03月 09日, 2022 | 阅读更多
Vivo Capital’s Portfolio Company IO Biotech Announces an IPO Gallery Vivo Capital’s Portfolio Company IO Biotech Announces an IPO 美国投资项目 Vivo Capital’s Portfolio Company IO Biotech Announces an IPO 2022-03-09 14:24:30 03月 09日, 2022 | 阅读更多
Vivo Capital’s Portfolio Company Aadi BioSceince announced a FDA approval of FYARRO for Patients with Locally Advanced Unresectable or Metastatic Malignant Perivascular Epithelioid Cell Tumor (PEComa) Gallery Vivo Capital’s Portfolio Company Aadi BioSceince announced a FDA approval of FYARRO for Patients with Locally Advanced Unresectable or Metastatic Malignant Perivascular Epithelioid Cell Tumor (PEComa) 美国投资项目 Vivo Capital’s Portfolio Company Aadi BioSceince announced a FDA approval of FYARRO for Patients with Locally Advanced Unresectable or Metastatic Malignant Perivascular Epithelioid Cell Tumor (PEComa) 2022-03-09 14:23:29 03月 09日, 2022 | 阅读更多
Vivo Capital, Co-Leads a $75m Series A Round of Financing in Ablaze Pharmaceuticals Gallery Vivo Capital, Co-Leads a $75m Series A Round of Financing in Ablaze Pharmaceuticals 美国投资项目 Vivo Capital, Co-Leads a $75m Series A Round of Financing in Ablaze Pharmaceuticals 2022-03-09 14:22:32 03月 09日, 2022 | 阅读更多
Vivo Capital, Leads a $200m Series A Round of Financing in Avistone Pharmaceuticals Gallery Vivo Capital, Leads a $200m Series A Round of Financing in Avistone Pharmaceuticals 美国投资项目 Vivo Capital, Leads a $200m Series A Round of Financing in Avistone Pharmaceuticals 2022-03-09 14:21:40 03月 09日, 2022 | 阅读更多